Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of S-217622 in children aged 6 to under 12 years with SARS-CoV-2 infection
jRCT2031230140Phase 3Active, not recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Ensitrelvir with Placebo (2 arms). Primary endpoints: Adverse events, Laboratory tests and 2 more. Started Jun 2023; status: active, not recruiting.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031230140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230140.